Hotline:
+ 49 (0) 2204 2918806

Market studies for category Cardiovascular

Items 1 to 10 of 730 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 73
  1. Net price*
    Year
  2. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Charlesson LLC. - Product Pipeline Review - 2013

    Global Markets Direct
    24 pages
    Global Market Direct’s pharmaceuticals report, “Charlesson LLC. - Product Pipeline Review - 2013” provides data on the Charlesson LLC.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is
    Englisch | Zukunftsanalyse | SKU: 386368
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Myasthenia Gravis – Pipeline Review, H1 2013

    Global Markets Direct
    59 pages
    Introduction Global Markets Direct’s, 'Myasthenia Gravis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Myasthenia Gravis, complete with latest updates, and special features on late-stage and discontinued projects. It also
    Englisch | Report | SKU: 329747
  4. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    27 pages
    Global Market Direct’s pharmaceuticals report, “Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013” provides data on the Stemedica Cell Technologies, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued a
    Englisch | Zukunftsanalyse | SKU: 386432
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Encephalomyelitis - Pipeline Review, H2 2013

    Global Markets Direct
    56 pages
    Global Markets Direct’s, 'Encephalomyelitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Encephalomyelitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p
    Englisch | Zukunftsanalyse | SKU: 381376
  6. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2013

    Global Markets Direct
    20 pages
    Global Market Direct’s pharmaceuticals report, “Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2013” provides data on the Sentinext Therapeutics Sdn Bhd’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dor
    Englisch | Zukunftsanalyse | SKU: 386496
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2013

    Global Markets Direct
    86 pages
    Global Markets Direct’s, 'Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Alpha- Antitrypsin Deficiency, complete with latest updates, and special features on late-stage and discontinued project
    Englisch | Zukunftsanalyse | SKU: 386208
  8. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Helsinn Healthcare S.A. - Product Pipeline Review - 2013

    Global Markets Direct
    43 pages
    Global Market Direct’s pharmaceuticals report, “Helsinn Healthcare S.A. - Product Pipeline Review - 2013” provides data on the Helsinn Healthcare S.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
    Englisch | Zukunftsanalyse | SKU: 386560
  9. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Acute Promyelocytic Leukemia - Pipeline Review, H2 2013

    Global Markets Direct
    41 pages
    Global Markets Direct’s, 'Acute Promyelocytic Leukemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Acute Promyelocytic Leukemia, complete with latest updates, and special features on late-stage and discontinued projects.
    Englisch | Zukunftsanalyse | SKU: 386272
  10. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Pulmonary Embolism - Pipeline Review, H1 2014

    Global Markets Direct
    91 pages
    Global Markets Direct’s, ‘Pulmonary Embolism - Pipeline Review, H1 2014’, provides an overview of the Pulmonary Embolism’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pulmonary Embolism, complete with comparative analysis at various stages, therapeutics assessment by drug
    Englisch | Zukunftsanalyse | SKU: 394131
  11. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    31 pages
    Global Market Direct’s pharmaceuticals report, “Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2013” provides data on the Collegium Pharmaceutical, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dor
    Englisch | Zukunftsanalyse | SKU: 386336

Items 1 to 10 of 730 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 73